why ?
say 280 mill shares on issue (world wide) - just how many would you need to buy back to make any impact ?
Analysts are critical of them going the oxide route and leaving the sulphates for the moment - the other issue are the remaining Oz assets
Only way to "grow" is better and cheaper production and a healthy balance sheet.
- Forums
- ASX - By Stock
- AQG
- lets get our head around valuation
lets get our head around valuation, page-21
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AQG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online